ASH Abstract No 1
Efficacy and safety of ibrutinib combined with standard first-line treatment or as substitute for autologous stem cell transplantation in younger patients with mantle cell lymphoma: results from the randomized TRIANGLE trial by the European MCL Network
M Dreyling, et al.
We invite you to apply for the above mentioned award which is endowed with 5.000 €.
further information follows
During the annual EHA annual conference in Vienna June 10-12, the Czernecki Donnelly Prize 2022 has been awarded to Lorenz Thurner, University hospital Homburg, for his manuscript on autoantibodies in mantle cell lymphoma.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Lorenz Thurner,1 Natalie Fadle,1 J€org Thomas Bittenbring,1 Evi Regitz,1 Rita Schuck,1 Onur Cetin,1 Ariane Stuhr,2 Torben Rixecker,1 Niels Murawski,1 Viola Poeschel,1 Dominic Kaddu-Mulindwa,1 Klaus-Dieter Preuss,1 Stephan Stilgenbauer,1 Olivier Hermine,2 Hanneke C. Kluin-Nelemans,3 Sylvia Hartmann,4 Martin Dreyling,5 Christiane Pott,6 Moritz Bewarder,1,_ and Eva Hoster5,7, _blood® 10 JUNE 2021 | VOLUME 137, NUMBER 23, 3251-3258
Based on the electronical poll in December 2021, we are happy to announce the new members of the European MCL board (in alphabetical order):
During the annual meeting in Paris, October 28-30, the Czernecki Donnelly Prize 2021 has been awarded to Silvia Bea, Hospital Clinic Barcelona, for her work
Ferran Nadeu#, et al, Sílvia Beà*, Elias Campo*. Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020 Sep 17;136(12):1419-1432.
The 1st Czernecki Donnelly Prize of the European MCL Network was awarded to Elisabeth Silkenstedt on the EHA 25 virtual for her work "Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy" (Journal of Experimental & Clinical Cancer Research (2019) 38: 446).